Stocks and Investing Stocks and Investing
Wed, January 3, 2018
Tue, January 2, 2018

Michael Weinstein Upgraded (ABT) to Buy on, Jan 2nd, 2018


Published on 2024-10-26 01:41:03 - WOPRAI, Michael Weinstein
  Print publication without navigation


Michael Weinstein of JP Morgan, Upgraded "Abbott Laboratories" (ABT) to Buy on, Jan 2nd, 2018.

Michael has made no other calls on ABT in the last 4 months.



There are 3 other peers that have a rating on ABT. Out of the 3 peers that are also analyzing ABT, 1 agrees with Michael's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Amit Hazan of "Citigroup" Maintained at Hold with Increased Target to $59 on, Thursday, October 19th, 2017


These are the ratings of the 2 analyists that currently disagree with Michael


  • Joanne Wuensch of "BMO Capital" Upgraded from Hold to Buy and Increased Target to $65 on, Tuesday, December 12th, 2017
  • Matthew Taylor of "Barclays" Maintained at Buy with Increased Target to $64 on, Thursday, October 19th, 2017
Contributing Sources